According to a press release, BC Platforms has agreed a collaboration with the Australian Breast Cancer Tissue Bank (ABCTB). The aim of this partnership will be to integrate ABCTB tissue sample data in the platform developed by BC Platforms, which, the press release explains, should contribute to improving therapeutic outcomes in the treatment of breast cancer.
BC Platforms is aiming to create the world’s largest healthcare and industrial platform via which the genomic and clinical data of individuals can be accessed. The company is obtaining the data for this project by agreeing a series of partnerships with global biobanks.
The ABCTB is based at the University of Sydney’s Westmead Institute for Medical Research. It has stored data pertaining to more than 10,000 tissue samples from approximately 5,000 people in addition to data on their treatment.
“Our collaboration with BC Platforms is a new pathway to facilitate worldwide access to the ABCTB resource”, comments Christine Clarke, Emeritus Professor at The University of Sydney, in the press release. This has the potential to accelerate the translation of research results into clinical practice, according to Clarke.
BC Platforms is headquartered in Zurich. According to information from the company itself, it additionally operates out of offices located in Boston, Vancouver, London and the Finnish city of Espoo.
Key insights from industry leaders regarding talent, tax, IP and choice of location.
Erfahren Sie mehr über den Erfolg der Life-Sciences-Industrie und die Innovation in der Region.
Erfahren Sie mehr zur Biotechindustrie und Innovation in der Schweiz.
This PDF outlines the key advantages of doing business in Greater Zurich and how we help.
This handbook provides information and data on Switzerland’s key locational advantages.